Home | Recruitment

Pending

Trials by recruitment status

Public Title Date of registration Sponsor
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations 22/05/2021 CIM
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms 22/05/2021 CPN
Itolizumab for Relapsing Remitting Multiple Sclerosis 22/05/2015 CIM
Safety and pharmacokinetics of CIGB-552 22/05/2015 CIGB
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study 21/12/2020 BIOCEN
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX 21/05/2021 CIM
Nimotuzumab in COVID-19 21/05/2021 CIM
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate 2013-06-19 FINLAY
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) 2013-06-06 CIGB
Vidatox 30CH in advanced malignant tumors-Primary health care-Phase IV 2013-05-21 LABIOFAM
Nimotuzumab for the treatment of high grade of malignancy tumors 2013-02-01 CIMAB
Interferon Combination in basal cell carcinoma (InCarbacel-V study) 2013-02-01 CIGB
Safety with interferon in skin carcinomas (SCIENCE study) 2013-01-30 CIGB
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) 2013-01-17 CIGB
D-004 in patients with Bening Prostatic Hyperplasia 2013-01-04 CPN
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection 2012-10-12 CIGB
iorEPOCIM-Stroke-Phase I 2012-09-17 CIMAB
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series 2012-09-12 CIGB
THERESA-4 Study 2011-10-25 CIGB
Teravac HIV in chronic HIV-1. 2011-08-10 CIGB